Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Hangzhou Tigermed Consulting Co., Ltd. Class H ( (HK:3347) ) is now available.
Hangzhou Tigermed Consulting Co., Ltd. announced a change in the payment date for the final dividend of its H Shares for the year 2024, moving it to July 11, 2025. This change affects shareholders of the H Shares, while details for the A Shares dividend distribution will be available on the Shenzhen Stock Exchange website.
The most recent analyst rating on (HK:3347) stock is a Buy with a HK$38.00 price target. To see the full list of analyst forecasts on Hangzhou Tigermed Consulting Co., Ltd. Class H stock, see the HK:3347 Stock Forecast page.
More about Hangzhou Tigermed Consulting Co., Ltd. Class H
Hangzhou Tigermed Consulting Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the consulting industry. The company is listed on the Hong Kong Stock Exchange and is involved in providing consulting services.
Average Trading Volume: 4,296,181
Technical Sentiment Signal: Buy
Current Market Cap: HK$42.25B
Find detailed analytics on 3347 stock on TipRanks’ Stock Analysis page.